Biofrontera Inc. Business Operations Contracts & Agreements

10 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Placement Agency Agreement, dated February 19, 2024, by and between Biofrontera Inc. and Roth Capital Partners, LLC
Agency Agreements
Biofrontera Inc.
Pharmaceuticals
NY
2024
Confidential Settlement Agreement and Mutual Release, dated as of December 27, 2023 and effective as of December 22, 2023, by and between the Company and Maruho
Settlement Agreements
Biofrontera Inc.
Pharmaceuticals
NY
2024
Placement Agency Agreement, dated October 30, 2023, by and between Biofrontera Inc. and Roth Capital Partners, LLC
Agency Agreements
Biofrontera Inc.
Pharmaceuticals
NY
2023
Amendment No. 1 to Settlement Agreement dated as of October 12, 2023, between Biofrontera Inc., Hermann Luebbert, John J. Borer, Loretta M. Wedge, Beth J. Hoffman, Kevin D. Weber...
Settlement Agreements
Biofrontera Inc.
Pharmaceuticals
2023
Confidential Settlement and General Release Agreement, dated as of May 25, 2023, between the Company and Erica Monaco
Settlement Agreements
Biofrontera Inc.
Pharmaceuticals
2023
Settlement Agreement dated April 11, 2023 between Biofrontera Inc., Hermann Luebbert, John J. Borer, Loretta M. Wedge, Beth J. Hoffman, Kevin D. Weber and Biofrontera AG
Settlement Agreements
Biofrontera Inc.
Pharmaceuticals
2023
Amended Settlement Allocation Agreement dated as of March 31, 2022 between the Company and Biofrontera AG
Settlement Agreements
Biofrontera Inc.
Pharmaceuticals
2022
Intercompany Services Agreement dated January 1, 2016, between the Company, Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH
Services Agreements
Biofrontera Inc.
Pharmaceuticals
2021
Amended and Restated Master Contract Services Agreement dated September [__] 2021, by and among the Company, Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH
Services Agreements
Biofrontera Inc.
Pharmaceuticals
MA
2021
Master Contract Services Agreement dated July 2, 2021, by and among the Company, Biofrontera AG, Biofrontera Pharma GmbH and Biofrontera Bioscience GmbH
Services Agreements
Biofrontera Inc.
Pharmaceuticals
MA
2021